ID: ALA4757434

Max Phase: Preclinical

Molecular Formula: C44H60N10O9

Molecular Weight: 873.02

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12

Standard InChI:  InChI=1S/C44H60N10O9/c1-29(2)32-14-17-53-40(32)41(47-28-48-53)49-30-6-8-31(9-7-30)51-18-20-52(21-19-51)38(57)13-12-36(55)46-16-23-62-25-27-63-26-24-61-22-15-45-34-5-3-4-33-39(34)44(60)54(43(33)59)35-10-11-37(56)50-42(35)58/h3-5,14,17,28-31,35,45H,6-13,15-16,18-27H2,1-2H3,(H,46,55)(H,47,48,49)(H,50,56,58)/t30-,31+,35?

Standard InChI Key:  NACJXPBPXDVAEF-XRCHNQPISA-N

Associated Targets(Human)

Cereblon/IRAK3 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Interleukin-1 receptor-associated kinase 3 577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Interleukin-1 receptor-associated kinase 4 5917 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 873.02Molecular Weight (Monoisotopic): 872.4545AlogP: 2.18#Rotatable Bonds: 21
Polar Surface Area: 218.14Molecular Species: NEUTRALHBA: 15HBD: 4
#RO5 Violations: 2HBA (Lipinski): 19HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 8.02CX LogP: 1.37CX LogD: 0.66
Aromatic Rings: 3Heavy Atoms: 63QED Weighted: 0.09Np Likeness Score: -1.02

References

1. Degorce SL,Tavana O,Banks E,Crafter C,Gingipalli L,Kouvchinov D,Mao Y,Pachl F,Solanki A,Valge-Archer V,Yang B,Edmondson SD.  (2020)  Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase.,  63  (18): [PMID:32803978] [10.1021/acs.jmedchem.0c01125]

Source